Literature DB >> 18236694

Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents.

A Alisi1, C Balsano.   

Abstract

Hepatocellular carcinoma (HCC) is a common cancer worldwide. A majority of HCC patients present with an unresectable or metastatic HCC and systemic therapy with cytotoxic agents provides marginal benefits. Some evidence suggests that certain natural phytochemical compounds used in conjunction with chemotherapeutic agents could enhance therapeutic efficacy by sensitizing cells to treatment.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18236694     DOI： 10.1301/nr.2007.dec.550-553

Source DB:  PubMed          Journal:  Nutr Rev        ISSN： 0029-6643            Impact factor:   7.110


  6 in total

1.  Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.

Authors:  Zhengyun Zou; Li Xie; Jia Wei; Lixia Yu; Xiaoping Qian; Junhao Chen; Tingting Wang; Baorui Liu
Journal:  BMC Complement Altern Med       Date:  2012-04-30       Impact factor: 3.659

2.  Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells.

Authors:  Cheng-Cheung Chen; Dar-Shih Hsieh; Kao-Jean Huang; Yi-Lin Chan; Po-Da Hong; Ming-Kung Yeh; Chang-Jer Wu
Journal:  Drug Des Devel Ther       Date:  2014-05-08       Impact factor: 4.162

3.  3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.

Authors:  Wen-Xue Li; Li-Ping Chen; Min-Ying Sun; Jun-Tao Li; Hua-Zhang Liu; Wei Zhu
Journal:  Oncotarget       Date:  2015-09-15

4.  Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.

Authors:  Muhammad Khan; Ting Li; Muhammad Khalil Ahmad Khan; Azhar Rasul; Faisal Nawaz; Meiyan Sun; Yongchen Zheng; Tonghui Ma
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

5.  A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.

Authors:  Minjie Mao; Xueping Wang; Hui Sheng; Yijun Liu; Lin Zhang; Shuqin Dai; Pei-Dong Chi
Journal:  BMC Cancer       Date:  2018-11-28       Impact factor: 4.430

6.  Novel prognostic scores based on serum ferritin/globulin ratio in patients with hepatocellular carcinoma.

Authors:  Wen Liu; Qunxi Chen; Minjie Mao; Runkun Han; Yijun Liu; Xueping Wang
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.